Mallika Singh

Company: Revolution Medicines

Job title: VP, Translational Research

Seminars:

Targeting RAS Mutant GI Cancers – Treatment Strategies and Resistance Mechanisms 9:30 am

Unmet medical need in RAS mutant GI cancers RAS(ON) Targeted Therapies for RAS mutant GI cancers: mutantselective and RASMulti inhibitors Application of biomarker-driven combination strategiesRead more

day: Day Two